LGMN and Parkinson disease: Pathway analysis also highlighted that legumain protease activity corresponds to cell junction regulation and neurodegenerative pathways (Figure 4e,f), which correlates with its known contribution to pathologies such as Alzheimer's and Parkinson's disease (Kang et al., 2022; Zhang et al., 2017).